Literature DB >> 1712336

Immunophenotyping of lymphocytes in liver tissue of patients with chronic liver diseases by flow cytometry.

X M Li1, L J Jeffers, K R Reddy, M de Medina, M Silva, S Villanueva, N G Klimas, V Esquenazi, E R Schiff.   

Abstract

Immunological factors are important in the pathogenesis of a spectrum of hepatobiliary diseases. To characterize the nature of specific immunological responses in liver disease, we determined lymphocyte changes in liver tissue and in blood using flow cytometry. A total of 113 liver biopsy specimens was collected from patients with the following diseases: 19 chronic hepatitis B; 39 chronic non-A, non-B hepatitis; 27 alcoholic liver disease; 10 hepatic malignancy; 8 autoimmune hepatitis; 6 fatty liver and 4 primary biliary cirrhosis. The lymphocytes were isolated from the liver biopsy specimens by mechanical and enzymatic methods. The lymphocyte yield was 7,901 +/- 575 cells/mg of liver tissue. The viability of lymphocytes was 97.7% +/- 0.3%. Lymphocytes were stained with four pairs of two-color mixed fluorescein-conjugated monoclonal antibodies, including T4-T8 (CD4/CD8), T11-B1 (CD2-CD20), NKH1-T8 (CD56-CD8), IL-2R1-T11 (CD25-CD2), and the ratios were determined by an Epics Profile flow cytometer. Immunophenotyping of lymphocytes in whole blood samples was simultaneously analyzed. Variability in lymphocyte yield and different patterns of lymphocyte subsets were found in the liver biopsy specimens. The yields of lymphocytes from patients with chronic non-A, non-B and autoimmune hepatitis were highest, and the lowest yield was from patients with fatty liver. Patients with primary biliary cirrhosis, fatty liver and hepatic malignancy had relatively high ratios of CD4/CD8, CD56/CD8 and CD25/CD2; whereas patients with chronic hepatitis B, autoimmune hepatitis and non-A, non-B hepatitis had lower ratios of CD4/CD8, CD56/CD8 and CD25/CD2. No difference in lymphocyte ratios between the patients with cirrhotic and noncirrhotic alcoholic liver disease was found.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712336     DOI: 10.1002/hep.1840140120

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  Immune surveillance of liver cancer in non-alcoholic fatty liver disease: excess lipids cause CD4 T-cells loss and promote hepatocellular carcinoma development.

Authors:  Ralf Weiskirchen; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2016-10       Impact factor: 7.293

2.  T-lymphocyte subpopulations as factors predicting clinical response to interferon in hepatitis C virus-related chronic active hepatitis.

Authors:  V Guadagnino; B Caroleo; A Izzi; G De Rosa; R D'Amelio
Journal:  Infection       Date:  1995 May-Jun       Impact factor: 3.553

3.  Comparison of intrahepatic lymphocytes from normal and growth hormone transgenic mice with chronic hepatitis and liver cancer.

Authors:  C L Hardy; P S Bhathal; K J Snibson; T E Adams
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

4.  Isolation of murine intrahepatic immune cells employing a modified procedure for mechanical disruption and functional characterization of the B, T and natural killer T cells obtained.

Authors:  K G Blom; M Rahman Qazi; J B Noronha Matos; B D Nelson; J W DePierre; M Abedi-Valugerdi
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

5.  CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis.

Authors:  M P Leon; G Spickett; D E Jones; M F Bassendine
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

6.  Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha.

Authors:  J A Quiroga; J Martin; M Pardo; V Carreño
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

7.  Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice.

Authors:  Angela Moya-Pérez; Alexander Neef; Yolanda Sanz
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.